AstraZeneca and the Bellvitge University Hospital in Spain are launching the first pilot program of the HearO™ app developed by Israel’s  Cordio Medical (see here previously) which can detect heart disease when the patient speaks on a smartphone. https://www.einnews.com/pr_news/634340933/astrazeneca-bellvitge-university-hospital-begin-pilot-of-cordio-medical-s-app-that-monitors-heart-failure-by-voice

Hebrew University researchers have discovered in lab tests that autism indicators increase as Nitric Oxide increases in the brain. Conversely, inhibiting production of NO increased “social” behavior, and interest in new objects while reducing repetitiveness and anxiety. https://www.jpost.com/health-and-wellness/mind-and-spirit/article-743947 https://www.israelnationalnews.com/news/371790 https://onlinelibrary.wiley.com/doi/10.1002/advs.202205783

Israel’s Clearmind Medicine has been granted permission to begin trials at Sheba Medical Center of MEAI (5-methoxy-2-aminoindane) – a synthetic compound developed in Canada to treat alcoholics. Clearmind spent years making the MEAI-based oral capsules conform to medical standards. https://nocamels.com/2023/05/biotech-firm-using-psychedelics-to-treat-alcohol-addiction/ … Continue reading →

Researchers at Israel’s Weizmann Institute have analyzed the build-up of ammonia that impairs immune cells in 50% of cancer patients. It blocks the protein regulator HNF4-alpha, causing weight loss and tumor growth. In lab tests, restoring HNF4-alpha production stops weight … Continue reading →